Cargando…

Metabolite-derived protein modifications modulating oncogenic signaling

Malignant growth is defined by multiple aberrant cellular features, including metabolic rewiring, inactivation of tumor suppressors and the activation of oncogenes. Even though these features have been described as separate hallmarks, many studies have shown an extensive mutual regulatory relationsh...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yawen, Vandekeere, Anke, Xu, Min, Fendt, Sarah-Maria, Altea-Manzano, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549695/
https://www.ncbi.nlm.nih.gov/pubmed/36226054
http://dx.doi.org/10.3389/fonc.2022.988626
_version_ 1784805727556075520
author Liu, Yawen
Vandekeere, Anke
Xu, Min
Fendt, Sarah-Maria
Altea-Manzano, Patricia
author_facet Liu, Yawen
Vandekeere, Anke
Xu, Min
Fendt, Sarah-Maria
Altea-Manzano, Patricia
author_sort Liu, Yawen
collection PubMed
description Malignant growth is defined by multiple aberrant cellular features, including metabolic rewiring, inactivation of tumor suppressors and the activation of oncogenes. Even though these features have been described as separate hallmarks, many studies have shown an extensive mutual regulatory relationship amongst them. On one hand, the change in expression or activity of tumor suppressors and oncogenes has extensive direct and indirect effects on cellular metabolism, activating metabolic pathways required for malignant growth. On the other hand, the tumor microenvironment and tumor intrinsic metabolic alterations result in changes in intracellular metabolite levels, which directly modulate the protein modification of oncogenes and tumor suppressors at both epigenetic and post-translational levels. In this mini-review, we summarize the crosstalk between tumor suppressors/oncogenes and metabolism-induced protein modifications at both levels and explore the impact of metabolic (micro)environments in shaping these.
format Online
Article
Text
id pubmed-9549695
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95496952022-10-11 Metabolite-derived protein modifications modulating oncogenic signaling Liu, Yawen Vandekeere, Anke Xu, Min Fendt, Sarah-Maria Altea-Manzano, Patricia Front Oncol Oncology Malignant growth is defined by multiple aberrant cellular features, including metabolic rewiring, inactivation of tumor suppressors and the activation of oncogenes. Even though these features have been described as separate hallmarks, many studies have shown an extensive mutual regulatory relationship amongst them. On one hand, the change in expression or activity of tumor suppressors and oncogenes has extensive direct and indirect effects on cellular metabolism, activating metabolic pathways required for malignant growth. On the other hand, the tumor microenvironment and tumor intrinsic metabolic alterations result in changes in intracellular metabolite levels, which directly modulate the protein modification of oncogenes and tumor suppressors at both epigenetic and post-translational levels. In this mini-review, we summarize the crosstalk between tumor suppressors/oncogenes and metabolism-induced protein modifications at both levels and explore the impact of metabolic (micro)environments in shaping these. Frontiers Media S.A. 2022-09-23 /pmc/articles/PMC9549695/ /pubmed/36226054 http://dx.doi.org/10.3389/fonc.2022.988626 Text en Copyright © 2022 Liu, Vandekeere, Xu, Fendt and Altea-Manzano https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liu, Yawen
Vandekeere, Anke
Xu, Min
Fendt, Sarah-Maria
Altea-Manzano, Patricia
Metabolite-derived protein modifications modulating oncogenic signaling
title Metabolite-derived protein modifications modulating oncogenic signaling
title_full Metabolite-derived protein modifications modulating oncogenic signaling
title_fullStr Metabolite-derived protein modifications modulating oncogenic signaling
title_full_unstemmed Metabolite-derived protein modifications modulating oncogenic signaling
title_short Metabolite-derived protein modifications modulating oncogenic signaling
title_sort metabolite-derived protein modifications modulating oncogenic signaling
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549695/
https://www.ncbi.nlm.nih.gov/pubmed/36226054
http://dx.doi.org/10.3389/fonc.2022.988626
work_keys_str_mv AT liuyawen metabolitederivedproteinmodificationsmodulatingoncogenicsignaling
AT vandekeereanke metabolitederivedproteinmodificationsmodulatingoncogenicsignaling
AT xumin metabolitederivedproteinmodificationsmodulatingoncogenicsignaling
AT fendtsarahmaria metabolitederivedproteinmodificationsmodulatingoncogenicsignaling
AT alteamanzanopatricia metabolitederivedproteinmodificationsmodulatingoncogenicsignaling